Latest News and Press Releases

Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Glaucoma - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. The clinical trial report offers a...

Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Glaucoma Therapeutics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)" has been added to ...

Dublin, June 23, 2025 (GLOBE NEWSWIRE) -- The "Acute Ocular Pain Market - A Global and Regional Analysis: Focus on Indication and Region - Analysis and Forecast, 2025-2035" report has been added to ...

Financing supports SpyGlass Pharma’s platform through the readout of two Phase III pivotal trials ALISO VIEJO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic...

All patients achieved 20/30 or better best corrected distance visual acuity (BCDVA)Significant IOP reduction at 18 months was also demonstrated with 100% of patients off all topical IOP-lowering...

For immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health...

For immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health...

BVI Medical, announced that it has received 510(k) clearance from the U.S. FDA for its innovative glaucoma surgical system, Leos™

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses &...

Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a...